UW Medicine offers second drug for early Alzheimer’s
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
Scientists Identify Key Enzyme in Alzheimer’s Disease That Links Brain Inflammation to Memory Loss
On Apr. 14, 2025, a research team at the Institute for Basic Science (IBS) in Korea announced they…
New mouse models can bridge gap in Alzheimer’s research
On Apr. 7, 2025, in a landmark study, researchers at University of Nebraska Medical Center (UNMC) announced they…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Tufts Research suggests Connection Between Concussions, Viruses, and Alzheimer’s
On Jan. 7, 2025, researchers at Tufts University and Oxford University announced they have uncovered mechanisms connecting trauma…
New Research Identifies Key Cellular Mechanism Driving Alzheimer’s Disease
On Dec. 23, 2024, researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC)…
University of Queensland ultrasound treatment for Alzheimer’s licensed to new startup
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
How fast is your brain ageing? Proteins in blood offer clues
On Dec. 9, 2024, neurologists at Fudan University in Shanghai, China have identified 13 proteins in the blood…
Biotechnology | Chemical | Diagnostics | Disease | Neurology
TGen-ASU study revealed lasting effects of common herbicide on brain health
On Dec. 4, 2024 a study led by researchers from TGen and Arizona State University showed that pre-clinical models exposed…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Alzheimer’s and alcohol use disorder share similar gene expression patterns
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biology | Biotechnology | Diagnostics | Disease | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
first drug approved for early Alzheimer’s disease in the UK
On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Diagnostics | Disease | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
Stanford University launched $75 million brain disease initiative
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment
On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…
Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
Biotechnology | Disease | Neurology | NIH | Therapeutics
NIH augmented large scale study of Alzheimer’s disease biomarkers
On Sept. 10, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
Alzheimer’s trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
Research on brain structure highlighted cells linked to Alzheimer’s and autism
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…